These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 22947327

  • 1. UMOD as a susceptibility gene for end-stage renal disease.
    Reznichenko A, Böger CA, Snieder H, van den Born J, de Borst MH, Damman J, van Dijk MC, van Goor H, Hepkema BG, Hillebrands JL, Leuvenink HG, Niesing J, Bakker SJ, Seelen M, Navis G, REGaTTA (REnal GeneTics TrAnsplantation) Groningen group.
    BMC Med Genet; 2012 Sep 05; 13():78. PubMed ID: 22947327
    [Abstract] [Full Text] [Related]

  • 2. A single nucleotide polymorphism in the UMOD promoter is associated with end stage renal disease.
    Chen T, Wang Q, Li G, Wang L.
    BMC Med Genet; 2016 Dec 09; 17(1):95. PubMed ID: 27938332
    [Abstract] [Full Text] [Related]

  • 3. Non-diabetic end-stage renal disease in Saudis associated with polymorphism of MYH9 gene but not UMOD gene.
    Adam KM, Mohammed AM, Elamin AA.
    Medicine (Baltimore); 2020 Jan 09; 99(3):e18722. PubMed ID: 32011449
    [Abstract] [Full Text] [Related]

  • 4. Common variants in UMOD associate with urinary uromodulin levels: a meta-analysis.
    Olden M, Corre T, Hayward C, Toniolo D, Ulivi S, Gasparini P, Pistis G, Hwang SJ, Bergmann S, Campbell H, Cocca M, Gandin I, Girotto G, Glaudemans B, Hastie ND, Loffing J, Polasek O, Rampoldi L, Rudan I, Sala C, Traglia M, Vollenweider P, Vuckovic D, Youhanna S, Weber J, Wright AF, Kutalik Z, Bochud M, Fox CS, Devuyst O.
    J Am Soc Nephrol; 2014 Aug 09; 25(8):1869-82. PubMed ID: 24578125
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of UMOD genotype on long-term graft survival after kidney transplantation in patients treated with cyclosporine-based therapy.
    Abdel-Hady Algharably E, Beige J, Kreutz R, Bolbrinker J.
    Pharmacogenomics J; 2018 Apr 09; 18(2):227-231. PubMed ID: 28418009
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Uromodulin in renal transplant recipients: elevated urinary levels and bimodal association with graft failure.
    Reznichenko A, van Dijk MC, van der Heide JH, Bakker SJ, Seelen M, Navis G.
    Am J Nephrol; 2011 Apr 09; 34(5):445-51. PubMed ID: 21968132
    [Abstract] [Full Text] [Related]

  • 16. UMOD polymorphism rs12917707 is not associated with severe or stable IgA nephropathy in a large Caucasian cohort.
    Dinic M, Ghisdal L, Racapé J, Thibaudin L, Gatault P, Essig M, Le Meur Y, Noël C, Touchard G, Merville P, Ajarchouh Z, Mariat C, Abramowicz M, Abramowicz D, Alamartine E.
    BMC Nephrol; 2014 Aug 28; 15():138. PubMed ID: 25163389
    [Abstract] [Full Text] [Related]

  • 17. Uromodulin rs4293393 T>C variation is associated with kidney disease in patients with type 2 diabetes.
    Kumar V, Yadav AK, Kumar V, Bhansali A, Jha V.
    Indian J Med Res; 2017 Nov 28; 146(Suppol):S15-S21. PubMed ID: 29578190
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease.
    Shlipak MG, Li Y, Fox C, Coresh J, Grunfeld C, Whooley M.
    BMC Nephrol; 2011 Jan 14; 12():2. PubMed ID: 21235779
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.